# CoA-Z in Pantothenate Kinase-associated Neurodegeneration (PKAN)

> **NCT04182763** · NA · COMPLETED · sponsor: **Oregon Health and Science University** · enrollment: 77 (actual)

## Conditions studied

- Pantothenate Kinase-Associated Neurodegeneration

## Interventions

- **OTHER:** CoA-Z
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04182763
- **Lead sponsor:** Oregon Health and Science University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-04
- **Primary completion:** 2024-09-01
- **Final completion:** 2025-01-01
- **Target enrollment:** 77 (ACTUAL)
- **Last updated:** 2025-10-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04182763

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04182763, "CoA-Z in Pantothenate Kinase-associated Neurodegeneration (PKAN)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04182763. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*